| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |